Atsushi Takatori
Chiba, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Targeting Wnt/β-Catenin Pathway by DNA Alkylating Pyrrole-Imidazole Polyamide in Colon Cancer.
Journal: Cancer science
Published: May 14, 2025
Downregulation of sST2, a decoy receptor for interleukin-33, enhances subcutaneous tumor growth in murine pancreatic cancer cells.
Journal: FEBS open bio
Published: March 05, 2025
ATR Inhibition Synergizes With Alkylating PI Polyamide Targeting MYCN by Suppressing DNA Repair in MYCN-Amplified Neuroblastoma.
Journal: Cancer science
Published: December 09, 2024
Poly (ADP-ribose) polymerase inhibitor sensitized DNA damage caused by an alkylating pyrrole-imidazole polyamide targeting MYCN in neuroblastoma cells.
Journal: Biochemical and biophysical research communications
Published: August 09, 2024
Use of DNA-alkylating pyrrole-imidazole polyamides for anti-cancer drug sensitivity screening in pancreatic ductal adenocarcinoma.
Journal: Cancer medicine
Published: July 14, 2022
A novel risk stratification model based on the Children's Hepatic Tumours International Collaboration-Hepatoblastoma Stratification and deoxyribonucleic acid methylation analysis for hepatoblastoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 31, 2022
Editorial: Molecular Mechanisms and Treatment of MYCN-Driven Tumors.
Journal: Frontiers in oncology
Published: October 28, 2021
NLRR1 Is a Potential Therapeutic Target in Neuroblastoma and MYCN-Driven Malignant Cancers.
Journal: Frontiers in oncology
Published: February 19, 2021
Targeting the mutant PIK3CA gene by DNA-alkylating pyrrole-imidazole polyamide in cervical cancer.
Journal: Cancer science
Published: October 09, 2020
Forced expression of NR4A3 induced the differentiation of human neuroblastoma-derived NB1 cells.
Journal: Medical oncology (Northwood, London, England)
Published: April 27, 2019
Last Updated: 09/26/2026